138 related articles for article (PubMed ID: 12409829)
1. The assessment of pancreatic exocrine function by bentiromide test in patients with chronic portal vein thrombosis.
Egesel T; Unsal I; Dikmen G; Bayraktar Y
Pancreas; 2002 Nov; 25(4):355-9. PubMed ID: 12409829
[TBL] [Abstract][Full Text] [Related]
2. Cavernous transformation of the portal vein is associated with pancreatic duct atrophy.
Bayraktar Y; Balkanci F; Bayraktar M; Koseoglu T; Serap Arslan ; Uzunalimoglu B; Van Thiel DH; Kaythan B
Hepatogastroenterology; 1996; 43(10):954-60. PubMed ID: 8884320
[TBL] [Abstract][Full Text] [Related]
3. The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels.
Bayraktar Y; Balkanci F; Ozenc A; Arslan S; Koseoglu T; Ozdemir A; Uzunalimoglu B; Telatar H; Gurakar A; Van Thiel DH
Am J Gastroenterol; 1995 Nov; 90(11):2015-9. PubMed ID: 7485013
[TBL] [Abstract][Full Text] [Related]
4. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome.
Weizman Z; Forstner GG; Gaskin KJ; Kopelman H; Wong S; Durie PR
Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.
Hubbard VS; Wolf RO; Lester LA; Egge AC
Dig Dis Sci; 1984 Oct; 29(10):881-9. PubMed ID: 6206989
[TBL] [Abstract][Full Text] [Related]
6. The bentiromide test for pancreatic exocrine insufficiency.
Toskes PP
Pharmacotherapy; 1984; 4(2):74-80. PubMed ID: 6371722
[TBL] [Abstract][Full Text] [Related]
7. Assessment of exocrine pancreatic function by oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (Bentiromide): 5 years' clinical experience.
Lang C; Gyr K; Stalder GA; Gillessen D
Br J Surg; 1981 Nov; 68(11):771-5. PubMed ID: 6975148
[TBL] [Abstract][Full Text] [Related]
8. Exocrine pancreatic function as determined in a same-day test with use of bentiromide and p-aminosalicylic acid.
Berg JD; Chesner IM; Allen-Narker RA; Buckley BM; Lawson N
Clin Chem; 1986 Jun; 32(6):1010-2. PubMed ID: 3486726
[TBL] [Abstract][Full Text] [Related]
9. The bentiromide test using plasma p-aminobenzoic acid for diagnosing pancreatic insufficiency in young children. The effect of two different doses and a liquid meal.
Laufer D; Cleghorn G; Forstner G; Ellis L; Koren G; Durie P
Gastroenterology; 1991 Jul; 101(1):207-13. PubMed ID: 2044909
[TBL] [Abstract][Full Text] [Related]
10. Simplified oral pancreatic function test.
Puntis JW; Berg JD; Buckley BM; Booth IW; McNeish AS
Arch Dis Child; 1988 Jul; 63(7):780-4. PubMed ID: 3261963
[TBL] [Abstract][Full Text] [Related]
11. Bentiromide test is not affected in patients with small bowel disease or liver disease.
Meyer BM; Campbell DR; Curington CW; Toskes PP
Pancreas; 1987; 2(1):44-7. PubMed ID: 3494995
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.
Mee AS; Girdwood AH; Walker E; Gilinsky NH; Kottler RE; Marks IN
Gut; 1985 Nov; 26(11):1257-62. PubMed ID: 3877666
[TBL] [Abstract][Full Text] [Related]
13. BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared.
Bellentani S; Grisendi A; Rinaldi M; Bertolani P; Costa G; Agostini M; Mastella G; Balli F; Manenti F
Eur J Pediatr; 1984 Dec; 143(2):145-8. PubMed ID: 6335090
[TBL] [Abstract][Full Text] [Related]
14. Evaluating exocrine function tests for diagnosing chronic pancreatitis.
Kitagawa M; Naruse S; Ishiguro H; Nakae Y; Kondo T; Hayakawa T
Pancreas; 1997 Nov; 15(4):402-8. PubMed ID: 9361095
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of the NBT-PABA test in chronic pancreatitis].
Turecka-Kulesza E; Długosz J; Gabryelewicz A
Pol Arch Med Wewn; 1990 Dec; 84(6):363-9. PubMed ID: 2092325
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic duct evaluation: accuracy of portal venous phase 64 MDCT.
Anderson SW; Soto JA
Abdom Imaging; 2009; 34(1):55-63. PubMed ID: 18425544
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of postoperative exocrine pancreatic function using chymotrypsin labile peptide.
Manabe T; Yokota T; Tobe T
Jpn J Surg; 1982; 12(3):178-83. PubMed ID: 6982366
[TBL] [Abstract][Full Text] [Related]
18. Exocrine pancreatic function in the early period after pancreatoduodenectomy and effects of preoperative pancreatic duct obstruction.
Ohshio G; Tanaka T; Imamura T; Okada N; Yoshitomi S; Suwa H; Hosotani R; Imamura M
Dig Dis Sci; 1996 Oct; 41(10):1947-52. PubMed ID: 8888705
[TBL] [Abstract][Full Text] [Related]
19. BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.
Delchier JC; Soule JC
Gut; 1983 Apr; 24(4):318-25. PubMed ID: 6601041
[TBL] [Abstract][Full Text] [Related]
20. Colorimetric plasma assay for the bentiromide test (BT-PABA) for exocrine pancreatic insufficiency.
Gharbo SA; Boyer JA; Williamson MJ
Anal Biochem; 1985 Jul; 148(1):228-32. PubMed ID: 3876041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
